In recent trading session, Teladoc Health Inc (NYSE:TDOC) saw 0.99 million shares changing hands at last check today with its beta currently measuring 1.81. Company’s recent per share price level of $7.05 trading at -$0.29 or -4.02% at last check today assigns it a market valuation of $1.24B. That most recent trading price of TDOC’s stock is at a discount of -115.74% from its 52-week high price of $15.21 and is indicating a premium of 9.93% from its 52-week low price of $6.35. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.97 million shares which gives us an average trading volume of 7.22 million if we extend that period to 3-months.
For Teladoc Health Inc (TDOC), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 2.54. Splitting up the data highlights that, out of 19 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 10 suggested the stock as a Hold whereas 9 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Teladoc Health Inc (NYSE:TDOC) trade information
Upright in the red during last session for losing -4.02%, in the last five days TDOC remained trading in the red while hitting it’s week-highest on Tuesday, 05/13/25 when the stock touched $7.05 price level, adding 8.68% to its value on the day. Teladoc Health Inc’s shares saw a change of -22.50% in year-to-date performance and have moved -0.49% in past 5-day. Teladoc Health Inc (NYSE:TDOC) showed a performance of -1.33% in past 30-days. Number of shares sold short was 20.9 million shares which calculate 3.76 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 13 to the stock, which implies a rise of 45.77% to its recent value today. Analysts have been projecting 13 as a low price target for the stock while placing it at a high target of 13. It follows that stock’s current price would drop -84.4% in reaching the projected high whereas dropping to the targeted low would mean a loss of -84.4% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -33.66% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 81.42% while estimates for its earnings growth in next 5 years are of 46.21%.
Teladoc Health Inc (NYSE:TDOC)’s Major holders
Insiders are in possession of 0.83% of company’s total shares while institution are holding 75.57 percent of that, with stock having share float percentage of 76.21%. Investors also watch the number of corporate investors in a company very closely, which is 75.57% institutions for Teladoc Health Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at TDOC for having 21.61 million shares of worth $211.35 million. And as of 2024-06-30, it was holding 12.6952 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 17.22 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.1136 of outstanding shares, having a total worth of $168.38 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 5.25 shares of worth $36.83 million or 2.99% of the total outstanding shares. The later fund manager was in possession of 4.56 shares on Mar 31, 2025 , making its stake of worth around $31.97 million in the company or a holder of 2.60% of company’s stock.
